Long-term outcomes of carinal sleeve resection in non-small cell lung cancer

Yükleniyor...
Küçük Resim

Tarih

2020

Dergi Başlığı

Dergi ISSN

Cilt Başlığı

Yayıncı

Georg Thieme Verlag Kg

Erişim Hakkı

info:eu-repo/semantics/closedAccess

Özet

Background Carinal resections for non-small cell lung cancer (NSCLC) invading the carina are challenging cases that require a therapeutic strategy. The aim of this study was to compare the oncologic outcomes and complications of patients who underwent carinal resection. Methods Sixty-four patients who underwent carinal resection between 2005 and 2016 were evaluated. Data were retrospectively reviewed for indications, complications, and factors influencing long-term survival. Results The study included 51 patients (79.7%) who underwent sleeve pneumonectomy (sP) and 13 patients who underwent carinal sleeve lobectomy (csL) as a curative therapy. Nine patients (14.1%) received induction chemotherapy. Complications were observed in 31 patients (48.8%), including 24 patients (47.1%) in the sP group and 7 patients (53.8%) in the csL group ( p = 0.662). Six patients (9.4%) developed bronchopleural fistula. The 30-day mortality rate was 10.9% ( n = 7). The 5- and 10-year survival rates were 42.2 and 23.1%, respectively. N2 and R1 were identified as factors affecting survival ( p = 0.029 and p = 0.047). Conclusion Carinal resections have acceptable morbidity, mortality, and long-term survival outcomes in central NSCLC. The main factors affecting survival are complete resection and nodal status. The results of csL were similar to those of sP. Therefore, we believe that csL should be performed in all eligible patients.

Açıklama

Anahtar Kelimeler

Carinal Resection, Non-Small Cell Lung Cancer, Central, Tumors, Lobectomy

Kaynak

Thoracic and Cardiovascular Surgeon

WoS Q Değeri

Q3

Scopus Q Değeri

Q2

Cilt

68

Sayı

2

Künye

Sezen, C. B., Kocaturk, C. I., Bilen, S., Kalafat, C. E., Cansever, L., Dincer, S. I., & Bedirhan, M. A. (2020). Long-term outcomes of carinal sleeve resection in non-small cell lung cancer. The Thoracic and cardiovascular surgeon, 68(02), 190-198.